Annotated Medicine and Device Lists

Lamotrigine

This medicine is present in:

List Section Observation
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC Others observations:
INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS SALVO: TABLETAS DISPERSABLES

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cns Anticonvulsants-Miscellaneous No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 28. Anticonvulsivos Others observations:
Masticable y dispensable.
Mexico. Cuadro Basico de Medicamentos - 2017 14. NEUROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Belize. National Drug Formulary 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.07.01 Control of Epilepsy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Peru 05. Anticonvulsants/Antiepileptics No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. Cns Anticonvulsants-Miscellaneous No observations
Costa Rica. Caja Costarricense de Seguro Social. 2019 28. Anticonvulsivos No observations
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. No observations
Mexico. Cuadro Basico de Medicamentos - 2017 14. NEUROLOGIA No observations
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 N. SISTEMA NERVOSO No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures
Barbados. Barbados National Drug Formulary (BNDF) 28.12.92 Miscellaneous Anticonvulsants No observations
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations
Cayman Islands Health Services Authority Pharmacy Drug Formulary 04.07.01 Control of Epilepsy No observations

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
WHO Model List of Essential Medicines (2021) 05. ANTICONVULSANTS/ ANTIEPILEPTICS No observations
Haiti. National List of Essential Medicines 05. Antiepileptics/ Anticonvulsants Others observations:
As an adjunct therapy for treatment-resistant partial or generalized seizures

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations

This medicine is present in:

List Section Observation
Bahamas. Drug Formulary 05.01 Anticonvulsants No observations

Information Resources: Lamotrigine

No information available